S4 E17, Adrienne Mendoza - Chief Operating Officer of BBG Advanced Therapies

Solving More Than Science with Adrienne MendozaCell and gene therapy is advancing rapidly, but science alone isn’t enough.In this episode of She Leads Biotech, Adrienne Mendoza, Chief Operating Officer of BBG Advanced Therapies, shares what’s really needed to move the field forward, from improving access and infrastructure to rethinking how these therapies reach patients.We also explore her journey over the past year, building a stronger presence in the industry, translating complex science for broader audiences, and the realities of leading through a challenging and evolving market.A practical and honest look at where the field is today, and what it will take to get to the next stage.Chapters00:00 Introduction02:00 Stepping into a New Role at BBG Advanced Therapies05:00 How the Role of a COO Evolves08:30 Building Presence and Community in CGT12:00 Making Complex Science Understandable16:00 The Mobile Leukapheresis Bus21:00 Access Challenges in Cell & Gene Therapy27:00 What Needs to Change in the System33:00 Industry Challenges and Optimism38:00 What the Next 5 Years Could Look Like41:00 Life Outside of Biotech#SheLeadsBiotech #CellAndGeneTherapy #BiotechLeadership #LifeSciences #CNAUSAExecutiveSearch